MANNKIND CORP. NEW DL-,01 |
USA |
Gesundheit |
US56400P7069 / A2DMZL |
NNFN (Frankfurt) / MNKD (NASDAQ) |
FRA:NNFN, ETR:NNFN, NNFN:GR, NASDAQ:MNKD |
- |
https://mannkindcorp.com/ |
MannKind Corporation is a biopharmaceutical compan..
>Volltext.. |
1179.84 Mio. EUR |
1157.84 Mio. EUR |
258.41 Mio. EUR |
71.24 Mio. EUR |
28.09 Mio. EUR |
0.1 EUR |
131.09 Mio. EUR |
48.82 Mio. EUR |
29.1 Mio. EUR |
1.6 |
10.46% |
154.07% |
- |
- |
- |
- |
MANNKIND |
29.08.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|